About Abiret 250 mg Tablet
Abiret 250 mg tablet is a cancer medicine containing abiraterone acetate, used in men with certain advanced prostate cancers. It works by lowering the body's production of androgens, the hormones that can help these tumours grow.
There are 4 brands of Abiraterone Acetate listed in Bangladesh. By unit price, Abiret is among the cheapest of them.
What is Abiret 250 mg Tablet?
Abiret 250 mg tablet contains abiraterone acetate, a type of cytotoxic chemotherapy medicine. It blocks an enzyme in the body that makes androgens, the male hormones that can encourage prostate cancer cells to grow. By reducing androgen levels, it is used in men with advanced prostate cancer that has spread, either when the cancer no longer responds to standard hormone treatment or in some newly diagnosed high-risk cases. It is given together with a corticosteroid and usually with another hormone-lowering treatment. Only a qualified cancer specialist decides whether it is suitable and how it should be combined with other medicines.
Uses of Abiret
Abiret 250 mg tablet is used in men with metastatic castration-resistant prostate cancer, meaning the cancer has spread and no longer responds to standard hormone therapy. It is also used in some men with metastatic high-risk castration-sensitive prostate cancer. It is taken together with a corticosteroid such as prednisone, and a gonadotropin-releasing hormone analogue is given at the same time, or the man has had both testicles removed. Your cancer specialist will confirm whether this medicine is right for your situation.
How to use Abiret
Abiret 250 mg tablet is swallowed whole with water and must not be crushed or chewed. It should be taken on an empty stomach, at least one hour before or two hours after a meal. The doctor decides the dose, how often it is taken and how long the course lasts; never change these yourself. It is usually taken with a corticosteroid, and your doctor will explain the schedule. If you miss a dose or are unsure, ask your doctor or pharmacist rather than adjusting it yourself.
Side effects of Abiret
Common side effects include tiredness, joint pain, high blood pressure, nausea, swelling, low potassium, hot flushes, diarrhoea, vomiting, cough, headache and upper respiratory infections. Some people develop more serious problems, such as liver problems, hormone-related fluid retention or adrenal gland problems. Tell your doctor promptly about severe tiredness, swelling, fast heartbeat, unusual weight change, yellowing of the skin or eyes, or feeling very unwell. Your doctor will arrange regular checks during treatment.
Safety and precautions
Before starting Abiret 250 mg tablet, tell your doctor about heart disease, high blood pressure, low potassium, liver problems or any past adrenal problems, because these need close monitoring. Blood pressure, potassium and liver function are checked regularly during treatment. This medicine is not established for use in women; it can harm a developing baby and is not intended for pregnancy or breastfeeding. Anyone with an allergy to abiraterone acetate or the tablet's other ingredients should not take it. Tell your doctor about all other medicines you take, as some can interact with it.
Frequently asked questions
What is the price of Abiret 250 mg tablet?
The listed price is ৳ 500.00. Ask your pharmacist about current availability and any other costs, such as doctor visits, tests or the other medicines taken with it.
What side effects should I watch for, and when should I call the doctor?
Watch for severe tiredness, swelling, fast heartbeat, unusual weight change, or yellowing of the skin or eyes. Call your doctor promptly if these occur or if you feel very unwell. Regular blood pressure, potassium and liver checks are part of treatment.
What is Abiret 250 mg tablet used for, and what kind of medicine is it?
It is a cytotoxic chemotherapy medicine containing abiraterone acetate. It is used in men with certain advanced prostate cancers that have spread, taken together with a corticosteroid and usually another hormone-lowering treatment. Your cancer specialist decides if it suits you.
How should Abiret 250 mg tablet be taken?
Swallow the tablet whole with water on an empty stomach, at least one hour before or two hours after food, and do not crush or chew it. The doctor decides the dose, frequency and length of the course. Ask your doctor or pharmacist if anything is unclear.
- Strength
- 250 mg
Price in Bangladesh
৳ 490 ৳ 500.00 2% off unit price
Price updated: 18 Nov 2026
Indications
Abiret is a CYP17 inhibitor indicated in combination with prednisone for the treatment of patients with
- Metastatic castration-resistant prostate cancer (CRPC).
- Metastatic high-risk castration-sensitive prostate cancer (CSPC).
Pharmacology
Abiraterone Acetate is converted in vivo to Abiraterone, an androgen biosynthesis inhibitor, that inhibits 17 α-hydroxylase/C17, 20-lyase (CYP17). This enzyme is expressed in testicular, adrenal, and prostatic tumor tissues and is required for androgen biosynthesis. CYP17 catalyzes two sequential reactions:
1. The conversion of pregnenolone and progesterone to their 17 α-hydroxy derivatives by 17 α-hydroxylase activity and
2. The subsequent formation of dehydroepiandrosterone (DHEA) and androstenedione, respectively, by C17, 20 lyase activity. DHEA and androstenedione are androgens and are precursors of testosterone. Inhibition of CYP17 by Abiraterone can also result in increased mineralocorticoid production by the adrenals. Androgen sensitive prostatic carcinoma responds to treatment that decreases androgen levels. Androgen deprivation therapies, such as treatment with GnRH agonists or orchiectomy, decrease androgen production in the testes but do not affect androgen production by the adrenals or in the tumor.
Abiraterone Acetate decreased serum testosterone and other androgens in patients in the placebo-controlled clinical trial. It is not necessary to monitor the effect of Abiraterone Acetate on serum testosterone levels. Changes in serum prostate specific antigen (PSA) levels may be observed but have not been shown to correlate with clinical benefit in individual patients.
Dosage & Administration
Recommended Dose For Metastatic CRPC: The recommended dose of Abiraterone Acetate is 1,000 mg (two 500 mg tablets or four 250 mg tablets) orally once daily with Prednisone 5 mg orally twice daily.
Recommended Dose For Metastatic High-Risk CSPC: The recommended dose of Abiraterone Acetate is 1,000 mg (two 500 mg tablets or four 250 mg tablets) orally once daily with Prednisone 5 mg administered orally once daily.
Patients receiving Abiraterone Acetate should also receive a gonadotropin-releasing hormone (GnRH) analog concurrently or should have had bilateral orchiectomy. Abiraterone Acetate must be taken on an empty stomach, at least one hour before or at least two hours atier a meal. The tablets should be swallowed whole with water. Do not crush or chew tablets.
Dose Modification:
- For patients with baseline moderate hepatic impairment (Child-Pugh Class B), reduce the Abiraterone Acetate starting dose to 250 mg once daily.
- For patients who develop hepatotoxicity during treatment, hold Abiraterone Acetate until recovery. Retreatment may be initated at a reduced dose. Abiraterone Acetate should be discontinued if patients develop severe hepatotoxicity.
- Avoid concomitant strong CYP3A4 inducers (e.g., Phenytoin, Carbamazepine, Rifampin, Rifabutin, Rifapentine, Phenobarbital) during Abiraterone Acetate treatment. If a strong CYP3A4 inducer must be co-administered, increase the Abiraterone Acetate dosing frequency to twice a day only during the co-administration period (e.g., from 1,000 mg once daily to 1,000 mg twice a day). Reduce the dose back to the previous dose and frequency, if the concomitant strong CYP3A4 inducer is discontinued. Or, as directed by the registered physician.
Pediatric Use: The safety and effectiveness in pediatric patients have not been established.
Interaction
Drugs That Inhibit Or Induce CYP3A4 Enzymes: Based on in vitro data, Abiret is a substrate of CYP3A4. In a dedicated drug interaction trial, co-administration of Rifampin, a strong CYP3A4 inducer, decreased exposure of Abiret by 55%. Avoid concomitant strong CYP3A4 inducers during Abiret treatment. If a strong CYP3A4 inducer must be co-administered, increase the Abiret dosing frequency. In a dedicated drug interaction trial, co-administration of ketoconazole, a strong inhibitor of CYP3A4, had no clinically meaningful effect on the pharmacokinetics of Abiret.
Effects Of Abiret On Drug Metabolizing Enzymes: Abiret is an inhibitor of the hepatic drug-metabolizing enzymes CYP2D6 and CYP2C8. In a CYP2D6 drug-drug interaction trial, the Cmax and AUC of Dextromethorphan (CYP2D6 substrate) were increased 2.8- and 2.9-fold, respectively, when Dextromethorphan was given with Abiret 1,000 mg daily and Prednisone 5 mg twice daily. Avoid co-administration of Abiret with substrates of CYP2D6 with a narrow therapeutic index (e.g., Thioridazine). If alternative treatments cannot be used, consider a dose reduction of the concomitant CYP2D6 substrate drug. In a CYP2C8 drug-drug interaction trial in healthy subjects, the AUC of Pioglitazone (CYP2C8 substrate) was increased by 46% when Pioglitazone was given together with a single dose of 1,000 mg Abiret. Therefore, patients should be monitored closely for signs of toxicity related to a CYP2C8 substrate with a narrow therapeutic index if used concomitantly with Abiret.
Contraindications
Hypersensitivity to the Abiraterone acetate or to any of the excipients of Abiraterone.
Side Effects
The most common adverse reactions are fatigue, arthalgia, hypertension, nausea, edema, hypokalemia, hot flush, diarrhea, vomiting, upper respiratory infection, cough, and headache.
Pregnancy & Lactation
The safety and efficacy of Abiraterone have not been established in females. Based on findings from animal studies and the mechanism of action, Abiraterone can cause fetal harm and potential loss of pregnancy. There are no human data on the use of Abiraterone in pregnant women. The safety and efficacy of Abiraterone have not been established in females. There is no information available on the presence of abiraterone acetate in human milk, or on the effects on the breastfed child or milk production.
Precautions & Warnings
Abiret may cause hypertension, hypokalemia, and fluid retention as a consequence of increased mineralocorticoid levels resulting from CYP17 inhibition. Patients should be monitored for hypertension, hypokalemia, and fluid retention at least once a month. Hypertension and hypokalemia should be controlled and corrected before and during treatment with Abiret. Patients should be monitored for symptoms and signs of adrenocortical insufficiency. Serum transaminases (ALT and AST) and bilirubin levels should be measured prior to starting treatment with Abiret, every two weeks for the first three months of treatment and monthly thereatier.
Overdose Effects
There is no specific antidote. In the event of an overdose, Abiret should be stopped, general supportive measures are undertaken, including monitoring for arrhythmias and cardiac failure and assess liver function.
Storage Conditions
Do not store above 25°C. Protect from light. Keep out of the reach of children.
Alternative brands of Abiraterone Acetate
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.